GFPT2 Antibody (Center)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application ![]()
| FC, IHC-P, WB, E |
---|---|
Primary Accession | O94808 |
Other Accession | Q4KMC4, Q9Z2Z9, Q08DQ2 |
Reactivity | Human |
Predicted | Bovine, Mouse, Rat |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit Ig |
Antigen Region | 175-201 aa |
Other Names | Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2, D-fructose-6-phosphate amidotransferase 2, Glutamine:fructose-6-phosphate amidotransferase 2, GFAT 2, GFAT2, Hexosephosphate aminotransferase 2, GFPT2 |
---|---|
Target/Specificity | This GFPT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 175-201 amino acids from the Central region of human GFPT2. |
Dilution | WB~~1:1000 IHC-P~~1:50~100 FC~~1:10~50 |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | GFPT2 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | GFPT2 |
---|---|
Function | Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins. |
Tissue Location | Highest levels of expression in heart, placenta, and spinal cord EMBL; AB016789; BAA74731.1; -; mRNA EMBL; BT009818; AAP88820.1; -; mRNA EMBL; BC000012; AAH00012.1; -; mRNA CCDS; CCDS43411.1; - RefSeq; NP_005101.1; NM_005110.3 SMR; O94808; - BioGRID; 115270; 37 IntAct; O94808; 11 STRING; 9606.ENSP00000253778; - DrugBank; DB00130; L-Glutamine MEROPS; C44.972; - iPTMnet; O94808; - PhosphoSitePlus; O94808; - BioMuta; GFPT2; - EPD; O94808; - jPOST; O94808; - MassIVE; O94808; - MaxQB; O94808; - PaxDb; O94808; - PeptideAtlas; O94808; - PRIDE; O94808; - ProteomicsDB; 50448; - Antibodypedia; 29588; 190 antibodies DNASU; 9945; - Ensembl; ENST00000253778; ENSP00000253778; ENSG00000131459 GeneID; 9945; - KEGG; hsa:9945; - UCSC; uc003mlw.2; human CTD; 9945; - DisGeNET; 9945; - EuPathDB; HostDB:ENSG00000131459.12; - GeneCards; GFPT2; - HGNC; HGNC:4242; GFPT2 HPA; ENSG00000131459; Tissue enhanced (adipose) MIM; 603865; gene neXtProt; NX_O94808; - OpenTargets; ENSG00000131459; - PharmGKB; PA28652; - eggNOG; KOG1268; Eukaryota GeneTree; ENSGT00940000156413; - HOGENOM; CLU_012520_5_2_1; - InParanoid; O94808; - KO; K00820; - OMA; TSYYSGC; - OrthoDB; 262871at2759; - PhylomeDB; O94808; - TreeFam; TF300864; - PathwayCommons; O94808; - Reactome; R-HSA-446210; Synthesis of UDP-N-acetyl-glucosamine UniPathway; UPA00113; UER00528 BioGRID-ORCS; 9945; 2 hits in 867 CRISPR screens ChiTaRS; GFPT2; human GenomeRNAi; 9945; - Pharos; O94808; Tbio PRO; PR:O94808; - Proteomes; UP000005640; Chromosome 5 RNAct; O94808; protein Bgee; ENSG00000131459; Expressed in layer of synovial tissue and 206 other tissues ExpressionAtlas; O94808; baseline and differential Genevisible; O94808; HS GO; GO:0005829; C:cytosol; TAS:Reactome GO; GO:0097367; F:carbohydrate derivative binding; IEA:InterPro GO; GO:0004360; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity; IBA:GO_Central GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl GO; GO:0006112; P:energy reserve metabolic process; TAS:ProtInc GO; GO:0006002; P:fructose 6-phosphate metabolic process; IBA:GO_Central GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW GO; GO:0006487; P:protein N-linked glycosylation; IBA:GO_Central GO; GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; TAS:Reactome GO; GO:0006047; P:UDP-N-acetylglucosamine metabolic process; IBA:GO_Central CDD; cd05008; SIS_GlmS_GlmD_1; 1 CDD; cd05009; SIS_GlmS_GlmD_2; 1 InterPro; IPR017932; GATase_2_dom InterPro; IPR035466; GlmS/AgaS_SIS InterPro; IPR035490; GlmS/FrlB_SIS InterPro; IPR005855; GlmS_trans InterPro; IPR029055; Ntn_hydrolases_N InterPro; IPR001347; SIS Pfam; PF01380; SIS; 2 SUPFAM; SSF56235; SSF56235; 1 TIGRFAMs; TIGR01135; glmS; 1 PROSITE; PS51278; GATASE_TYPE_2; 1 PROSITE; PS51464; SIS; 2 1: Evidence at protein level; Aminotransferase; Glutamine amidotransferase; Phosphoprotein; Polymorphism; Reference proteome; Repeat; Transferase INIT_MET 1 /note="Removed" /evidence="ECO:0000250" CHAIN 2..682 /note="Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2" /id="PRO_0000135283" DOMAIN 2..288 /note="Glutamine amidotransferase type-2" /evidence="ECO:0000255|PROSITE-ProRule:PRU00609" DOMAIN 360..499 /note="SIS 1" /evidence="ECO:0000255|PROSITE-ProRule:PRU00797" DOMAIN 531..672 /note="SIS 2" /evidence="ECO:0000255|PROSITE-ProRule:PRU00797" REGION 377..378 /note="Substrate-binding" /evidence="ECO:0000250|UniProtKB:Q06210" REGION 422..424 /note="Substrate-binding" /evidence="ECO:0000250|UniProtKB:Q06210" ACT_SITE 2 /note="For GATase activity" /evidence="ECO:0000250|UniProtKB:P14742" BINDING 427 /note="Substrate" /evidence="ECO:0000250|UniProtKB:Q06210" BINDING 578 /note="Substrate" /evidence="ECO:0000250|UniProtKB:Q06210" MOD_RES 244 /note="Phosphoserine" /evidence="ECO:0000244|PubMed:23186163" VARIANT 471 /note="I -> V (in dbSNP:rs2303007)" /evidence="ECO:0000269|Ref.2" /id="VAR_013311" SEQUENCE 682 AA; 76931 MW; A090D75526F3192B CRC64; MCGIFAYMNY RVPRTRKEIF ETLIKGLQRL EYRGYDSAGV AIDGNNHEVK ERHIQLVKKR GKVKALDEEL YKQDSMDLKV EFETHFGIAH TRWATHGVPS AVNSHPQRSD KGNEFVVIHN GIITNYKDLR KFLESKGYEF ESETDTETIA KLIKYVFDNR ETEDITFSTL VERVIQQLEG AFALVFKSVH YPGEAVATRR GSPLLIGVRS KYKLSTEQIP ILYRTCTLEN VKNICKTRMK RLDSSACLHA VGDKAVEFFF ASDASAIIEH TNRVIFLEDD DIAAVADGKL SIHRVKRSAS DDPSRAIQTL QMELQQIMKG NFSAFMQKEI FEQPESVFNT MRGRVNFETN TVLLGGLKDH LKEIRRCRRL IVIGCGTSYH AAVATRQVLE ELTELPVMVE LASDFLDRNT PVFRDDVCFF ISQSGETADT LLALRYCKDR GALTVGVTNT VGSSISRETD CGVHINAGPE IGVASTKAYT SQFISLVMFG LMMSEDRISL QNRRQEIIRG LRSLPELIKE VLSLEEKIHD LALELYTQRS LLVMGRGYNY ATCLEGALKI KEITYMHSEG ILAGELKHGP LALIDKQMPV IMVIMKDPCF AKCQNALQQV TARQGRPIIL CSKDDTESSK FAYKTIELPH TVDCLQGILS VIPLQLLSFH LAVLRGYDVD FPRNLAKSVT VE |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
GFPT2 controls the flux of glucose into the hexosamine pathway. This protein most likely involved in regulating the availability of precursors for N-and O-linked glycosylation of proteins.
References
Edwards,T.L., et.al., Ann. Hum. Genet. 74 (2), 97-109 (2010)
Prasad,P., et.al., BMC Med. Genet. 11, 52 (2010)
Srinivasan,V., et.al., Clin. Biochem. 40 (13-14), 952-957 (2007)

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.